drugset / Trial / NCT00826358
Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From 5/45 mg Strength of ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) 45 mg and Rosuvastatin Calcium 5 mg
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and compare the pharmacokinetic parameters from the fixed dose combination ABT-143 relative to that from the co-administration of the two monotherapies.
Timeline
- Start
- 2008-11
- Primary completion
- 2008-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABT-143 | Unknown | 5 mg | — |
| Subject | ABT-143 | Unknown | 45 mg | — |
| Comparator | ABT-335 | Small molecule | 45 mg | — |
| Comparator | Rosuvastatin | Small molecule | 5 mg | — |
Indications
No indication recorded.